These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1696654)

  • 1. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Mitch S; Powell JR; Petrillo W; Cushman DW
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):139-46. PubMed ID: 1696656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
    Kishi K; Ikeda M
    Gen Pharmacol; 1993 Jul; 24(4):863-6. PubMed ID: 8224740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceranapril and cerebral blood flow autoregulation.
    Torup M; Waldemar G; Paulson OB
    J Hypertens; 1993 Apr; 11(4):399-405. PubMed ID: 8390507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme.
    DeForrest JM; Waldron TL; Krapcho J; Turk C; Rubin B; Powell JR; Cushman DW; Petrillo EW
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):887-94. PubMed ID: 2484083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SQ 27,786 and SQ 28,853: two angiotensin converting enzyme inhibitors with potent diuretic activity.
    DeForrest JM; Waldron TL; Powell JR; Floyd DM; Sundeen JE
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):154-9. PubMed ID: 2435992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
    Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
    Sadoshima S; Fujii K; Ooboshi H; Ibayashi S; Fujishima M
    Stroke; 1993 Oct; 24(10):1561-6; discussion 1566-7. PubMed ID: 8378962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659-(S)).
    Wolf PS; Mann WS; Suh JT; Loev B; Smith RD
    Fed Proc; 1984 Apr; 43(5):1322-5. PubMed ID: 6323222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits.
    Murthy VS; Waldron TL; Goldberg ME; Vollmer RR
    Eur J Pharmacol; 1977 Dec; 46(3):207-12. PubMed ID: 201471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor.
    Sakai K; Aono J; Shiraki Y; Hinohara Y; Akamatsu A; Tanaka S; Kuromaru K
    Tohoku J Exp Med; 1987 Aug; 152(4):363-74. PubMed ID: 3660405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.